학술논문
Prognostic and predictive impact of genes and signatures measured with the BC360 panel (Nanostring) in node positive (>= pN2a) high risk patients (pts) receiving dose dense (dd) versus standard dosed chemotherapy in an adjuvant randomized trial with a long term follow-up (FU)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445